Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2025-12-17 @ 1:29 AM
Study NCT ID:
NCT04679272
Status:
None
Last Update Posted:
2021-03-01 00:00:00
First Post:
2020-12-20 00:00:00
Brief Title:
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
Sponsor:
University Hospital Montpellier
Organization:
University Hospital, Montpellier
Study Overview
Official Title:
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA
Status:
None
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ProCOVRA
Brief Summary:
COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None